Dietary sodium: The dark horse amongst cardiovascular and renal risk factors

Nephrology Dialysis Transplantation

Volumn 23, Issue 7, 2008, Pages 2138-2141

  Mimran, Albert ^a   Du Cailar, Guilhem ^a  

^a LAPEYRONIE HOSPITAL   (France)

Author keywords

Hypertension; Left ventricular hypertrophy; Microalbuminuria; Sodium intake

Indexed keywords

SODIUM CHLORIDE;

ALBUMINURIA; CARDIOVASCULAR RISK; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; KIDNEY DISEASE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PULSE PRESSURE; REVIEW; RISK FACTOR; SODIUM INTAKE; SODIUM RESTRICTION;

ALBUMINURIA; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; HYPERTENSION; KIDNEY DISEASES; MALE; RISK FACTORS; SODIUM, DIETARY; VENTRICULAR REMODELING;

EID: 46849090719     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn160     Document Type: Review

References (44)

1. de Wardener HE, Kaplan NM. On the assertion that a moderate restriction of sodium intake may have adverse health effects. Am J Hypertens 1993; 6: 810-814
2. Al-Awqati Q. Evidence-based politics of salt and blood pressure. Kidney Int 2006; 69: 1707-1708
3. Cappuccio FP. Salt and cardiovascular disease. BMJ 2007; 334: 859-860
4. He FJ, de Wardener HE, MacGregor GA. Salt intake and cardiovascular mortality. Am J Med 2007; 120: 55-59
5. Alderman MH. Evidence relating dietary sodium to cardiovascular disease. J Am Coll Nutr 2006; 25(3 Suppl): 256S-261S
6. Luft FC, Fineberg NS, Sloan RS. Estimating dietary sodium intake in individuals receiving a randomly fluctuating intake. Hypertension 1982; 4: 805-808
7. Sanchez-Castillo CP, Warrender S, Whitehead TP et al. An assessment of the sources of dietary salt in a British population. Clin Sci (Lond) 1987; 72: 95-102
8. Intersalt Cooperative Research Group. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. BMJ 1988; 297: 319-328
9. Law MR, Frost CD, Wald NJ. By how much does dietary salt reduction lower blood pressure? I - Analysis of observational data among populations. BMJ 1991; 302: 811-815
10. Sacks FM, Svetkey LP, Vollmer et al. DASH - Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the Dietary approaches to stop hypertension (DASH) diet. N Engl J Med 2001; 344: 3-10
11. Hooper L, Bartlett C, Smith GD et al. Systematic review of long term effects of advice to reduce dietary salt in adults. BMJ 2002; 325: 628-637
12. Verdecchia P, Porcellati C, Reboldi G et al. Left ventricular hypertrophy as an independent predictor of acute cerebrovascular events in essential hypertension. Circulation 2001; 104: 2039-2044
13. Devereux RB, Wachtell K, Gerdts E et al. Dahlöf B. Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA 2004; 17: 2350-2356
14. Hillege HL, Fidler V, Diercks GF et al. Prevention of Renal and Vascular End Stage Disease (PREVEND) Study Group. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002; 106: 1777-1782
15. Arnlöv J, Evans JC, Meigs JB et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the framingham heart study. Circulation 2005; 112: 969-975
16. Olsen MH, Wachtell K, Ibsen He et al. LIFE Study Investigators. Reductions in albuminuria and in electrocardiographic left ventricular hypertrophy independently improve prognosis in hypertension: the LIFE study. J Hypertens 2006; 24: 775-781
17. Klausen KP, Scharling H, Jensen G et al. New definition of microalbuminuria in hypertensive subjects: association with incident coronary heart disease and death. Hypertension 2005; 46: 33-37
18. Wang TJ, Evans JC, Meigs JB et al. Low-grade albuminuria and the risks of hypertension and blood pressure progression. Circulation 2005; 111: 1370-1376
19. Stuveling EM, Bakker SJ, Hillege HL et al. PREVEND Study Group. C-reactive protein modifies the relationship between blood pressure and microalbuminuria. Hypertension 2004; 43: 791-796
20. Schmieder RE, Messerli FH, Garavaglia GE et al. Salt intake as a determinant of cardiac involvement in essential hypertension. Circulation 1988; 78: 951-956
21. du Cailar G, Ribstein J, Daures JP et al. Sodium and left ventricular mass in untreated hypertensive and normotensive subjects. Am J Physiol 1992; 263: H177-H181
22. Liebson PR, Grandits GA, Prineas RJ et al. Echocardiographic correlates of left ventricular structure among 844 midly hypertensive men and women in the treatment of mild hypertension study (TOMHS). Circulation 1993; 87: 476-486
23. Swaye PS, Gifford RW, Berretoni JN. Dietary salt and hypertension. Am J Cardiology 1972; 29: 33-38
24. du Cailar G, Ribstein J, Mimran A. Dietary sodium and target organ damage in essential hypertension. Am J Hypertens 2002; 15: 222-229
25. Dhingra R, Pencina M, Benjamin E et al. Cross-sectional relations of urinary sodium excretion to cardiac structure and hypertrophy. The Framingham heart study. Am J Hypertens 2004; 17: 891-896
26. Fox CS, Larson MG, Hwang SJ et al. Cross-sectional relations of serum aldosterone and urine sodium excretion to urinary albumin excretion in a community-based sample. Kidney Int 2006; 69: 2064-2069
27. Franklin SS, Khan SA, Wong ND et al. Is pulse pressure useful in predicting risk for coronary heart disease? The framingham heart study. Circulation 1999; 100: 354-360
28. du Cailar G, Mimran A, Fesler P et al. Dietary sodium and pulse pressure in normotensive and essential hypertensive subjects. J Hypertension 2004; 22: 697-703
29. Avolio AP, Fa-Quan D, Wei-Qiang L et al. Effect of aging on arterial distensibility in populations with high and low prevalence of hypertension: comparison between urban and rural communities in China.Circulation 1985; 71: 202-210
30. Avolio AP, Clyde KM, Beard TC et al. Improved arterial distensibility in normotensive subjects on a low salt diet. Arteriosclerosis 1986; 6: 166-169
31. Alderman MH, Cohen H, Madhavan S. Dietary sodium intake and mortality: the National Health and Nutrition Examination Survey (NHANES I). Lancet 1998; 351: 781-785
32. Cohen HW, Hailpern SM, Fang J et al. Sodium intake and mortality in the NHANES II follow-up study. Am J Med 2006; 119: 275-282
33. Shimazu T, Kuriyama S, Hozawa A et al. Dietary patterns and cardiovascular disease mortality in Japan: a prospective cohort study. Int J Epidemiol 2007; 36: 600-609
34. He J, Ogden LG, Vupputuri S et al. Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults. JAMA 1999; 282: 2027-2034
35. Tuomilehto J, Jousilahti P, Rastenyte D et al. Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study. Lancet 2001; 357: 848-851
36. Hu G, Jousilahti P, Peltonen M et al. Urinary sodium and potassium excretion and the risk of type 2 diabetes: a prospective study in Finland. Diabetologia 2005; 48: 1477-1483
37. Appel LJ, Espeland MA, Easter L et al. Effects of reduced sodium intake on hypertension control in older individuals: results from the Trial of Nonpharmacologic Interventions in the Elderly (TONE). Arch Intern Med 2001; 161: 685-693
38. Cook NR, Cutler JA, Obarzanek E et al. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ 2007; 334: 885-892
39. Nickenig G, Strehlow K, Roeling J et al. Salt induces vascular AT1 receptor overexpression in vitro and in vivo. Hypertension 1998; 31: 1272-1277
40. Gonzalez M, Lobos L, Castillo F et al. High-salt diet inhibits expression of angiotensin type 2 receptor in resistance arteries. Hypertension 2005; 45: 853-859
41. Takeda Y, Yoneda T, Demura M et al. Sodium-induced cardiac aldosterone synthesis causes cardiac hypertrophy. Endocrinology 2000; 141: 1901-1904
42. Cordaillat M, Rugale C, Casellas D et al. Cardiorenal abnormalities associated with high sodium intake: correction by spironolactone in rats. Am J Physiol (Regul Integr Comp Physiol) 2005; 289: R1137-R1143
43. Laffer CL, Bolterman RJ, Romero JC et al. Effect of Salt on isoprostanes in salt-sensitive essential hypertension. Hypertension 2006; 47: 434-440
44. Fang Y, Mu JJ, He LC et al. Salt loading on plasma asymmetrical dimethylarginine and the protective role of potassium supplement in normotensive salt-sensitive asians. Hypertension 2006; 48: 724-729